Cyclosporine Ophthalmic Solution for Inflammatory Dry Eye

Opinion
Video

Dry eye experts discuss Cyclosporine ophthalmic solution.

Video content above is prompted by the following question(s):

1. Cyclosporine ophthalmic solution, 0.1% (VEVYE)

Recent Videos
Cochair Kelly K. Nichols, OD, PhD, MPH, FAAO, highlights her passion for dry eye research and the vital collaboration between ophthalmology and optometry
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
Video 3 - "Approaching Asymptomatic Cases with Risk Factors"
Related Content
Sonoma Pharmaceuticals, EMC Pharma roll out collaboration to co-market expanded eye care product line

Sonoma Pharmaceuticals, EMC Pharma roll out collaboration to co-market expanded eye care product line

Article
Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 4)

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 4)

Podcast
Pearls detail targeted interventions for management of dry eye disease

Pearls detail targeted interventions for management of dry eye disease

Article
Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 3)

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 3)

Podcast
Eyenovia and SGN Nanopharma partner to develop treatment for chronic dry eye disease

Eyenovia and SGN Nanopharma partner to develop treatment for chronic dry eye disease

Article
Novaliq receives positive CHMP opinion for ciclosporin 0.1% solution, Vevizye

Novaliq receives positive CHMP opinion for ciclosporin 0.1% solution, Vevizye

Article
© 2024 MJH Life Sciences

All rights reserved.